Neurol. praxi. 2014;15(4):210-212

Duodopa in advanced Parkinson's disease in clinical practice - a case report

doc. MUDr. Martin Vališ, Ph.D.
Neurologická klinika, FN a LF UK, Hradec Králové

The case report describes a 63-year-old man with advanced Parkinson's disease at the stage of late motor and mental complications in whom, following the failure of classic pharmacotherapy, treatment with Duodopa was used in a long-term and safe manner.

Keywords: advanced Parkinson's disease, late motor and mental complications, Duodopa

Published: September 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vališ M. Duodopa in advanced Parkinson's disease in clinical practice - a case report. Neurol. praxi. 2014;15(4):210-212.
Download citation

References

  1. Aarsland D, Kurz MW. The epidemiology of dementia associated with Parinson's disease. J Neurol Sci 2010; 289(1-2): 18-22. Go to original source... Go to PubMed...
  2. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001; 16: 448-458. Go to original source... Go to PubMed...
  3. Antonini A. Continuous dopaminergic stimulation - from theory to clinical practice. Parkinsonism Relat Disord 2007; 13: 24-28. Go to original source... Go to PubMed...
  4. Baláž M. Hluboká mozková stimulace u Parkinsonovy nemoci. Neurol. praxi 2013; 14(5): 229-231.
  5. Hariz MI. Complication of deep brain stimulation surgery. Mov Disord 2002; 17(3): 162-166. Go to original source... Go to PubMed...
  6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184. Go to original source... Go to PubMed...
  7. Kianička B, Žák J, Bareš M. Využití perkutánní endoskopické gastrostomie - přehled indikací, popis techniky a současné trendy v neurologii. Cesk Slov Neurol N 2012; 75/108(2): 165-169.
  8. Menšíková K, Nestrašil I, Praško JP. Behaviorální komplikace dopaminergní terapie v pokročilé fázi Parkinsonově nemoci. Neurol. praxi, 2013; 14(2): 92-95.
  9. Nutt JG, Holford NHG. The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 1996; 39: 561-573. Go to original source... Go to PubMed...
  10. Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H. Duodenal levodopa infusion monotherapy vs. oral polypharmacy in advanced Parkinson disease. Neurology 2005; 64: 216-223. Go to original source... Go to PubMed...
  11. Obeso JA, Rodriguez-Oroz M, Marin C, Zamarbide I, Lanciego JL, Rodriguez-Diaz M. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 2004; 62: 17-30. Go to original source... Go to PubMed...
  12. Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A. LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 2014 Feb; 13(2): 141-149. Go to original source... Go to PubMed...
  13. Olanow CW, Stern MB, Sethi K. Scientific and clinical basis for the treatment of PD-2009. Neurology 2009; 72(4): 1-136. Go to original source... Go to PubMed...
  14. Vališ M, Taláb R, Waberžinek G, Štěpán P, Mulačová M. První zkušenosti s kontinuální dopaminergní stimulací u pokročilé Parkinsonovy choroby. Neurol. praxi, 2008; 9(3): 179-181.
  15. Wolters CHE. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease. Parkinsonism. Relat Disord 2007; 13: 18-23. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.